ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near St Louis, MO, USA:

RITUXIMAB + IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA

This research study is studying several new investigational drug combinations as a possible treatment for follicular lymphoma.The drugs invo...

Active, not recruiting
Follicular Lymphoma
Drug: Avelumab
Drug: PF04518600

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Saint Louis, Missouri, United States and 5 other locations

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Enrolling
Lymphoma, Non-Hodgkin
Drug: CC-99282
Drug: Tafasitamab

Phase 1, Phase 2

Celgene
Celgene

Saint Louis, Missouri, United States and 88 other locations

order to see how well it works in patients with untreated follicular lymphoma. Mosunetuzumab is an antibody that has been engineered to atta...

Enrolling
Lymphoma, Follicular
Follicular Lymphoma
Drug: Polatuzumab vedotin
Drug: Mosunetuzumab

Phase 2

The Washington University
The Washington University

Saint Louis, Missouri, United States

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

Phase 3

Celgene
Celgene

Saint Louis, Missouri, United States and 126 other locations

autologous stem cell transplant for patients with aggressive B cell lymphomas. Mosunetuzumab is an antibody that has been engineered to atta...

Enrolling
Follicular Lymphoma Grade 3
B Cell Lymphoma
Drug: Mosunetuzumab

Phase 1

The Washington University
The Washington University

Saint Louis, Missouri, United States

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Enrolling
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Chesterfield, Missouri, United States and 55 other locations

in participants with relapsed or refractory (R/R) CD30-expressing lymphomas.GEN3017 will be administered via subcutaneous injections.All par...

Enrolling
Classical Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Biological: GEN3017

Phase 1, Phase 2

Genmab
Genmab

Saint Louis, Missouri, United States and 5 other locations

This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...

Active, not recruiting
Relapsed/Refractory Peripheral T-Cell Lymphoma
Adult T Cell Leukemia/Lymphoma
Drug: Valemetostat Tosylate

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Saint Louis, Missouri, United States and 59 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: brentuximab vedotin
Drug: bleomycin

Phase 3

Takeda
Takeda

Saint Louis, Missouri, United States and 215 other locations

This is a First-in-Human Phase I trial of ATG-101 in Patients with Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas....

Enrolling
Mature B-cell Non-Hodgkin Lymphoma
Advanced Solid Tumor
Drug: ATG-101

Phase 1

Antengene
Antengene

Saint Louis, Missouri, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems